Mustang Bio, Inc.
MBIO
$0.74
$0.045.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.84% | 3.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 57.91% | 7.37% | |||
| Operating Income | -57.91% | -7.37% | |||
| Income Before Tax | -77.51% | -14.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -77.51% | -14.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -77.51% | -14.96% | |||
| EBIT | -57.91% | -7.37% | |||
| EBITDA | -56.64% | -7.37% | |||
| EPS Basic | -70.76% | -10.80% | |||
| Normalized Basic EPS | -70.58% | -10.87% | |||
| EPS Diluted | -70.76% | -10.80% | |||
| Normalized Diluted EPS | -70.58% | -10.87% | |||
| Average Basic Shares Outstanding | 3.99% | 3.68% | |||
| Average Diluted Shares Outstanding | 3.99% | 3.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||